Chlorine in PDB 8co7: Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066
Enzymatic activity of Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066
All present enzymatic activity of Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066:
4.6.1.1;
Protein crystallography data
The structure of Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066, PDB code: 8co7
was solved by
C.Steegborn,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
32.50 /
1.90
|
Space group
|
P 63
|
Cell size a, b, c (Å), α, β, γ (°)
|
99.291,
99.291,
99.403,
90,
90,
120
|
R / Rfree (%)
|
19.1 /
23.4
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066
(pdb code 8co7). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066, PDB code: 8co7:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 8co7
Go back to
Chlorine Binding Sites List in 8co7
Chlorine binding site 1 out
of 3 in the Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl501
b:24.6
occ:1.00
|
CL20
|
A:V9E501
|
0.0
|
24.6
|
1.0
|
C16
|
A:V9E501
|
1.7
|
26.4
|
1.0
|
N11
|
A:V9E501
|
2.7
|
25.3
|
1.0
|
C15
|
A:V9E501
|
2.8
|
25.6
|
1.0
|
HE2
|
A:PHE165
|
2.8
|
35.0
|
1.0
|
H151
|
A:V9E501
|
2.9
|
30.7
|
1.0
|
HG22
|
A:VAL167
|
3.0
|
30.9
|
1.0
|
HA
|
A:LEU166
|
3.1
|
34.5
|
1.0
|
HE3
|
A:LYS95
|
3.2
|
36.7
|
1.0
|
HB3
|
A:LEU94
|
3.2
|
26.8
|
1.0
|
H
|
A:VAL167
|
3.3
|
32.7
|
1.0
|
CE2
|
A:PHE165
|
3.3
|
29.1
|
1.0
|
HD13
|
A:LEU94
|
3.4
|
28.2
|
1.0
|
HG3
|
A:LYS95
|
3.4
|
35.4
|
1.0
|
HD2
|
A:PHE165
|
3.5
|
35.1
|
1.0
|
CD2
|
A:PHE165
|
3.7
|
29.3
|
1.0
|
HD2
|
A:LYS95
|
3.7
|
36.5
|
1.0
|
N
|
A:VAL167
|
3.8
|
27.3
|
1.0
|
HD23
|
A:LEU102
|
3.9
|
36.0
|
1.0
|
CA
|
A:LEU166
|
3.9
|
28.8
|
1.0
|
CE
|
A:LYS95
|
4.0
|
30.6
|
1.0
|
HG13
|
A:VAL167
|
4.0
|
29.1
|
1.0
|
CG2
|
A:VAL167
|
4.0
|
25.8
|
1.0
|
HZ2
|
A:LYS95
|
4.0
|
38.7
|
1.0
|
CB
|
A:LEU94
|
4.1
|
22.3
|
1.0
|
C12
|
A:V9E501
|
4.1
|
25.9
|
1.0
|
HB2
|
A:LEU94
|
4.1
|
26.8
|
1.0
|
HD12
|
A:LEU94
|
4.1
|
28.2
|
1.0
|
C
|
A:LEU166
|
4.1
|
29.4
|
1.0
|
C14
|
A:V9E501
|
4.1
|
25.9
|
1.0
|
CD
|
A:LYS95
|
4.1
|
30.4
|
1.0
|
O
|
A:PHE165
|
4.1
|
23.9
|
1.0
|
CD1
|
A:LEU94
|
4.1
|
23.5
|
1.0
|
CG
|
A:LYS95
|
4.2
|
29.5
|
1.0
|
CZ
|
A:PHE165
|
4.2
|
30.2
|
1.0
|
HD23
|
A:LEU166
|
4.2
|
40.1
|
1.0
|
HB2
|
A:LYS95
|
4.2
|
34.1
|
1.0
|
HZ
|
A:PHE165
|
4.4
|
36.3
|
1.0
|
HG21
|
A:VAL167
|
4.4
|
30.9
|
1.0
|
HG23
|
A:VAL167
|
4.4
|
30.9
|
1.0
|
NZ
|
A:LYS95
|
4.5
|
32.2
|
1.0
|
N
|
A:LEU166
|
4.5
|
26.2
|
1.0
|
C
|
A:PHE165
|
4.6
|
25.5
|
1.0
|
N13
|
A:V9E501
|
4.6
|
26.0
|
1.0
|
CG
|
A:LEU94
|
4.7
|
23.3
|
1.0
|
HZ1
|
A:LYS95
|
4.7
|
38.7
|
1.0
|
CB
|
A:VAL167
|
4.7
|
25.0
|
1.0
|
CG1
|
A:VAL167
|
4.7
|
24.2
|
1.0
|
HE2
|
A:LYS95
|
4.7
|
36.7
|
1.0
|
CB
|
A:LYS95
|
4.8
|
28.4
|
1.0
|
CD2
|
A:LEU102
|
4.8
|
30.0
|
1.0
|
CG
|
A:PHE165
|
4.8
|
28.1
|
1.0
|
HD22
|
A:LEU94
|
4.8
|
27.1
|
1.0
|
CA
|
A:VAL167
|
4.8
|
26.4
|
1.0
|
C
|
A:LEU94
|
4.9
|
23.7
|
1.0
|
HD22
|
A:LEU102
|
4.9
|
36.0
|
1.0
|
HD11
|
A:LEU94
|
4.9
|
28.2
|
1.0
|
HG2
|
A:LYS95
|
5.0
|
35.4
|
1.0
|
HB3
|
A:LEU166
|
5.0
|
38.8
|
1.0
|
HD21
|
A:LEU102
|
5.0
|
36.0
|
1.0
|
O
|
A:LEU166
|
5.0
|
30.2
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 8co7
Go back to
Chlorine Binding Sites List in 8co7
Chlorine binding site 2 out
of 3 in the Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl519
b:58.5
occ:1.00
|
H
|
A:GLN409
|
2.9
|
41.1
|
1.0
|
HG22
|
A:THR55
|
3.1
|
65.2
|
0.6
|
HA2
|
A:GLY408
|
3.4
|
40.4
|
1.0
|
O
|
A:HOH625
|
3.4
|
30.2
|
1.0
|
HE2
|
A:PHE392
|
3.7
|
42.5
|
0.7
|
N
|
A:GLN409
|
3.7
|
34.2
|
1.0
|
HA3
|
A:GLY408
|
3.8
|
40.4
|
1.0
|
OE2
|
A:GLU56
|
3.8
|
83.1
|
1.0
|
HB3
|
A:GLN409
|
3.9
|
60.4
|
1.0
|
CG2
|
A:THR55
|
4.0
|
54.3
|
0.6
|
CA
|
A:GLY408
|
4.0
|
33.6
|
1.0
|
HG21
|
A:THR55
|
4.0
|
65.2
|
0.6
|
HB2
|
A:GLN409
|
4.0
|
60.4
|
1.0
|
O
|
A:ILE390
|
4.1
|
31.6
|
1.0
|
HD2
|
A:PHE392
|
4.3
|
39.1
|
0.7
|
HB
|
A:THR55
|
4.3
|
68.0
|
0.4
|
CB
|
A:GLN409
|
4.3
|
50.4
|
1.0
|
CE2
|
A:PHE392
|
4.4
|
35.4
|
0.7
|
C
|
A:GLY408
|
4.4
|
32.6
|
1.0
|
HA
|
A:GLU56
|
4.4
|
75.0
|
1.0
|
HG23
|
A:THR55
|
4.4
|
65.2
|
0.6
|
HB3
|
A:SER59
|
4.6
|
74.6
|
1.0
|
CD
|
A:GLU56
|
4.6
|
81.8
|
1.0
|
HA
|
A:VAL391
|
4.6
|
36.0
|
0.6
|
O
|
A:THR55
|
4.6
|
51.2
|
1.0
|
CA
|
A:GLN409
|
4.7
|
38.1
|
1.0
|
OG
|
A:SER59
|
4.7
|
63.6
|
1.0
|
HA
|
A:VAL391
|
4.7
|
35.9
|
0.4
|
CD2
|
A:PHE392
|
4.7
|
32.6
|
0.7
|
OG1
|
A:THR55
|
4.8
|
56.6
|
0.4
|
HB
|
A:THR55
|
4.9
|
68.0
|
0.6
|
HG2
|
A:GLU56
|
4.9
|
90.2
|
1.0
|
H
|
A:LYS410
|
4.9
|
35.6
|
1.0
|
C
|
A:THR55
|
5.0
|
55.9
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 8co7
Go back to
Chlorine Binding Sites List in 8co7
Chlorine binding site 3 out
of 3 in the Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of Human Soluble Adenylyl Cyclase (Sac) in Complex with Inhibitor Tdi-09066 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl520
b:67.9
occ:1.00
|
H
|
A:LYS256
|
2.7
|
32.9
|
1.0
|
O
|
A:LYS256
|
3.0
|
26.3
|
1.0
|
HD22
|
A:LEU255
|
3.2
|
39.3
|
1.0
|
HB2
|
A:ASP258
|
3.4
|
40.2
|
1.0
|
N
|
A:LYS256
|
3.5
|
27.4
|
1.0
|
HD23
|
A:LEU261
|
3.5
|
33.6
|
1.0
|
HA
|
A:LEU255
|
3.7
|
35.0
|
1.0
|
HB3
|
A:LEU255
|
3.7
|
34.9
|
1.0
|
HD23
|
A:LEU255
|
3.8
|
39.3
|
1.0
|
HB3
|
A:ASP258
|
3.9
|
40.2
|
1.0
|
CD2
|
A:LEU255
|
3.9
|
32.8
|
1.0
|
C
|
A:LYS256
|
4.0
|
28.1
|
1.0
|
HD22
|
A:LEU261
|
4.0
|
33.6
|
1.0
|
HD13
|
A:ILE13
|
4.0
|
29.6
|
1.0
|
HB2
|
A:LYS256
|
4.0
|
40.9
|
1.0
|
CB
|
A:ASP258
|
4.0
|
33.5
|
1.0
|
OD2
|
A:ASP258
|
4.2
|
37.8
|
1.0
|
CD2
|
A:LEU261
|
4.2
|
28.0
|
1.0
|
CA
|
A:LYS256
|
4.2
|
28.8
|
1.0
|
CA
|
A:LEU255
|
4.3
|
29.2
|
1.0
|
C
|
A:LEU255
|
4.3
|
27.2
|
1.0
|
CB
|
A:LEU255
|
4.4
|
29.1
|
1.0
|
HD21
|
A:LEU261
|
4.5
|
33.6
|
1.0
|
HD21
|
A:LEU255
|
4.6
|
39.3
|
1.0
|
CB
|
A:LYS256
|
4.6
|
34.1
|
1.0
|
CG
|
A:ASP258
|
4.6
|
36.3
|
1.0
|
HD11
|
A:ILE13
|
4.7
|
29.6
|
1.0
|
O
|
A:HOH808
|
4.8
|
122.6
|
1.0
|
CG
|
A:LEU255
|
4.8
|
30.8
|
1.0
|
CD1
|
A:ILE13
|
4.8
|
24.7
|
1.0
|
|
Reference:
S.Sun,
M.Fushimi,
T.Rossetti,
N.Kaur,
J.Ferreira,
M.Miller,
J.Quast,
J.Van Den Heuvel,
C.Steegborn,
L.R.Levin,
J.Buck,
R.W.Myers,
S.Kargman,
N.Liverton,
P.T.Meinke,
D.J.Huggins.
Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led By Free Energy Perturbation. J.Chem.Inf.Model. V. 63 2828 2023.
ISSN: ESSN 1549-960X
PubMed: 37060320
DOI: 10.1021/ACS.JCIM.2C01577
Page generated: Tue Jul 30 08:04:19 2024
|